Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Shuangjia Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2138-8775; OpenAlex author ID A5024382630. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Impact of tertiary lymphoid structure-associated biomarkers on pancreatic cancer via a dual-disease analysis of psoriasis and pancreatic cancer. Last author DOI 10.1007/s12672-025-03082-1↗
  2. C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11. Co-author DOI 10.1007/s10142-024-01429-5↗
  3. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients wi… Co-author DOI 10.1007/s00259-021-05576-w↗
  4. MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2. Co-author DOI 10.7150/jca.43379↗
  5. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both… First author DOI 10.1007/s00432-012-1152-z↗
  6. Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. Co-author DOI 10.1371/journal.pone.0037222↗
  7. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions]. Co-author PMID 22883954↗
  8. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Co-author DOI 10.1007/s00280-011-1643-7↗
  9. Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions. Co-author DOI 10.1371/journal.pone.0023752↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hao Yu · 1 shared paper, 2025 · strength 0.28
  2. Zhimin Li · 1 shared paper, 2024 · strength 0.28
  3. Bin Li · 1 shared paper, 2021 · strength 0.16
  4. Yizhen Pang · 1 shared paper, 2022 · strength 0.13
  5. Liang Zhao · 1 shared paper, 2022 · strength 0.13
  6. Haojun Chen · 1 shared paper, 2022 · strength 0.13
  7. Bei Sun · 4 shared papers, 2011–2012 · strength 0.12
  8. Shangha Pan · 4 shared papers, 2011–2012 · strength 0.12
  9. Hongchi Jiang · 4 shared papers, 2011–2012 · strength 0.11
  10. Zhuoxin Cheng · 4 shared papers, 2011–2012 · strength 0.11
  11. Rui Kong · 4 shared papers, 2011–2012 · strength 0.11
  12. Yongwei Wang · 3 shared papers, 2011–2012 · strength 0.09
  13. Guang Jia · 3 shared papers, 2011–2012 · strength 0.08
  14. Xuewei Bai · 2 shared papers, 2011 · strength 0.05
  15. Dongbo Xue · 2 shared papers, 2011 · strength 0.05
  16. Gang Wang · 1 shared paper, 2012 · strength 0.03
  17. Hua Chen · 1 shared paper, 2011 · strength 0.02
  18. Yingmei Zhang · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.